German State Court Ruling Against Novartis Confirms Legality of HTA For Older Products
This article was originally published in The Pink Sheet Daily
Executive Summary
A State Social Court of Berlin-Brandenburg ruling against Novartis means that Germany's reimbursement bodies can move forward with the benefit assessment of older pharmaceutical products.